-
DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy
03 Feb 2026 15:44 GMT
… -directed DXd antibody drug conjugate (ADC) … indicated for the treatment of:
Contraindications
None … with foundational medicines fulvestrant and goserelin and aims … : RESEARCH FDA CLINICAL TRIALS BIOTECHNOLOGY GENERAL HEALTH PHARMACEUTICAL HEALTH SCIENCE …
-
MCAZ warns public over unauthorised Zoladex cancer drug on market
29 Jan 2026 02:52 GMT
… .
Goserelin Acetate (Zoladex) is a hormonal medicine commonly used in the treatment of … consumers Wednesday, MCAZ said the drug was being distributed through unapproved … of the approved distributor, Sky Pharmaceuticals.
By contrast, the unauthorised product …
-
<![CDATA[FDA OKs Study Progression of (Z)-Endoxifen in Metastatic Breast Cancer ]]>
06 Jan 2026 23:54 GMT
… quot;We appreciate the FDA's review and … goserelin (Zoladex) at 3.6 mg subcutaneously every 4 weeks, with treatment … trial within 6 months of registration, and allergy to any treatment drugs … Therapeutics wins 2025 Clinical Trials Arena Research and …
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
16 Dec 2025 03:09 GMT
… trial, said: “Trastuzumab deruxtecan plus pertuzumab is the only 1st-line treatment … with foundational medicines fulvestrant and goserelin and … BIOTECHNOLOGY HEALTH WOMEN PHARMACEUTICAL ONCOLOGY OTHER SCIENCE RESEARCH GENETICS CONSUMER SCIENCE CLINICAL TRIALS …
-
<![CDATA[Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials]]>
20 Oct 2025 22:21 GMT
… FirstWord Pharma, some doctors have had reservations around … breast cancer medicine and consultant medical oncologist at The … NATALEE trial (NCT03701334) of Kisqali (ribociclib) revealed that treatment … or letrozole) with goserelin as indicated.
The primary …
-
This is the new 'wonder' ingredient found in everything from weight-loss jabs to A-list treatments and 'bio-enhancement'... but as the 'Wild West' market thrives, our experts reveal the warnings you can't ignore
14 Oct 2025 11:10 GMT
… feed a tumour (such as goserelin or leuprolide for prostate and … very different from those in medical treatments. Beauty peptides are tiny, … success of peptides in clinical trials is being exploited by … did it properly under a doctor and it worked for me …
-
Enhertu demonstrated highly statistically significant and clinically meaningful improvement in IDFS vs. T─DM1 in DESTINY─Breast05 phase III trial in patients with high─risk early breast cancer following neoadjuvant therapy
30 Sep 2025 05:35 GMT
… DESTINY-Breast05 phase III trial showed Enhertu (trastuzumab … HER2-directed DXd antibody drug conjugate (ADC) discovered … . Trials in combination with other anti-cancer treatments, … with foundational medicines Faslodex (fulvestrant) and Zoladex (goserelin) and …
-
Enhertu plus pertuzumab granted Priority Review in US as 1st-line treatment for patients with HER2-positive metastatic breast cancer
25 Sep 2025 03:31 GMT
… Drug Administration (FDA) grants Priority Review to applications for medicines … was stratified by prior treatment (de novo metastatic … 47;or DESTINY-Lung05 trials. Continued approval in … foundational medicines Faslodex (fulvestrant) and Zoladex (goserelin) and …
-
Advances of Drug-Loaded Microsphere Technology for Targeted Immunotherapy Against Prostate Cancer
19 Sep 2025 16:43 GMT
… , Phase 2 Trial (the TRENDY Trial). Int J … received goserelin microsphere + ARV-766 microsphere embolization treatment, and … as collaboration across clinical medicine, data science, and … Drug Delivery Applications: An Overview of Recent Advances. Pharmaceutics. …
-
Can Epithelial-Myoepithelial Carcinoma of the Breast Benefit from TROP2 Antibody-Drug Conjugate?
11 Sep 2025 19:58 GMT
… 2 gene test, and goserelin was given for ovarian … United States Food and Drug Administration (FDA) approved the application … her overall survival. Local treatment (radiofrequency ablation) may be … review of the literature. Medicine. 2020;99(42):e22665. …
About
© 1995-2026